Mirum Pharmaceuticals Stock (NASDAQ: MIRM) stock price, news, charts, stock research, profile.
You can purchase shares of Mirum Pharmaceuticals (NASDAQ:MIRM) through any online brokerage.
Other companies in Mirum Pharmaceuticals’s space includes: Centessa Pharmaceuticals (NASDAQ:CNTA), Xencor (NASDAQ:XNCR), SpringWorks Therapeutics (NASDAQ:SWTX), Protagonist Therapeutics (NASDAQ:PTGX) and Kiniksa Pharmaceuticals (NASDAQ:KNSA).
Mirum Pharmaceuticals has a consensus price target of $55.87.
The stock price for Mirum Pharmaceuticals (NASDAQ: MIRM) is $44.15 last updated November 13, 2024 at 4:45 PM EST.
There are no upcoming dividends for Mirum Pharmaceuticals.
Mirum Pharmaceuticals’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Mirum Pharmaceuticals.
Mirum Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.